Sign In
Buy OPY
$99.90
+2.52 (+2.59%)
At Close: Jun 09, 2026
Papa Johns to Participate in the Oppenheimer 25™ Annual Consumer Growth and E-Commerce Conference
07:00am, Wednesday, 28'th May 2025
LOUISVILLE, Ky.--(BUSINESS WIRE)--Papa John's International, Inc. (Nasdaq: PZZA) (“Papa Johns®”) today announced that members of its leadership team will participate in the 2025 Oppenheimer Consu
Home Depot continues to manage a difficult & challenging backdrop well: Oppenheimer's Brian Nagel
07:32am, Tuesday, 20'th May 2025
Brian Nagel, Oppenheimer senior equity research analyst, joins 'Squawk Box' to break down Home Depot's quarterly earnings results.
Nutrien price target raised by $5 at Oppenheimer, here's why
08:03am, Tuesday, 13'th May 2025
07 Aug
Modine to Participate in Upcoming Oppenheimer Virtual Conference on May 8, 2025
09:00am, Tuesday, 06'th May 2025
RACINE, Wis. , May 6, 2025 /PRNewswire/ -- Modine (NYSE: MOD), a diversified global leader in thermal management technology and solutions, announced today that it will participate in the Oppenheimer
Custom Truck One Source to Participate in the Oppenheimer 20th Annual Industrial Growth Conference
06:30am, Friday, 02'nd May 2025
KANSAS CITY, Mo.--(BUSINESS WIRE)--Custom Truck One Source, Inc. (NYSE: CTOS) today announced that Chief Executive Officer, Ryan McMonagle, and Chief Financial Officer, Chris Eperjesy, will participat
Tejon Ranch Co. to Participate in Oppenheimer's 20th Annual Industrial Growth Conference
08:00am, Thursday, 01'st May 2025
TEJON RANCH, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co. (NYSE:TRC), (“Tejon” or the “Company”), a diversified real estate development and agribusiness company, today announced th
Snap-on to Present at Oppenheimer and Bank of America Investor Conferences
08:30am, Wednesday, 30'th Apr 2025
KENOSHA, Wis.--(BUSINESS WIRE)--Snap-on to present at two upcoming investor conferences.
McGrath to Present at the Oppenheimer 20th Annual Industrial Growth Conference
04:00pm, Tuesday, 29'th Apr 2025
LIVERMORE, Calif.--(BUSINESS WIRE)--McGrath RentCorp (“McGrath” or the “Company”) (Nasdaq: MGRC), a leading business-to-business rental company in North America, today announced that it will p
Lincoln Electric to Present at the Oppenheimer 20th Annual Industrial Growth Conference
04:30pm, Monday, 28'th Apr 2025
CLEVELAND--(BUSINESS WIRE)-- #LEA--Lincoln Electric Holdings, Inc. (Nasdaq: LECO) today announced that Gabriel Bruno, Executive Vice President and Chief Financial Officer, will speak at the Oppenheime
Oppenheimer Holdings Inc. Reports First Quarter 2025 Earnings
08:00am, Friday, 25'th Apr 2025
NEW YORK , April 25, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $30.7 million or $2.93 basic earnings per share for the first quar
Rockwell Automation to Present at Oppenheimer 20th Annual Industrial Growth Conference
07:00am, Thursday, 24'th Apr 2025
MILWAUKEE--(BUSINESS WIRE)--Rockwell Automation, Inc. (NYSE: ROK) Vice President, Investor Relations and Market Strategy, Aijana Zellner, will present virtually at Oppenheimer 20th Annual Industrial G
BofA, Oppenheimer latest on Wall St to slash S&P 500's annual target
10:04am, Monday, 07'th Apr 2025
BofA Global Research and Oppenheimer Asset Management on Monday became the latest Wall Street research firms to cut their year-end targets for the S&P 500 index to below the 6,000 mark in response to
Oppenheimer cuts S&P 500 target, still sees 15% upside in 2025
04:48am, Monday, 07'th Apr 2025
Oppenheimer Chief Investment Strategist John Stoltzfus cut the firm's year-end 2025 S&P 500 price target to 5,950 from 7,100, an upside of about 15% from the close on Friday. The announcement and deta
Oppenheimer's Brian Nagel: Trade 'safe havens' have been abolished by new tariffs
12:10pm, Thursday, 03'rd Apr 2025
Brian Nagel, Oppenheimer analyst, joins CNBC's 'Squawk on the Street' to discuss how companies can adapt their supply chains to account for new tariffs, whether it's feasible for companies to actually
Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit
08:00am, Wednesday, 02'nd Apr 2025
SAN DIEGO , April 2, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (th
